Galloula A, Rossi A, Gautier V, Minozzi C, Messas E, Mirault T
Médecine vasculaire, hôpital européen Georges-Pompidou, 20, rue Leblanc, 75015 Paris, France.
Médecine vasculaire, hôpital européen Georges-Pompidou, 20, rue Leblanc, 75015 Paris, France; Université Paris Descartes, Sorbonne Paris Cité, 75006 Paris, France.
J Mal Vasc. 2014 May;39(3):224-30. doi: 10.1016/j.jmv.2014.03.005. Epub 2014 Apr 5.
Portal vein thrombosis is an unusual condition and its association with an acute cytomegalovirus (CMV) infection is known but rarely reported. We present here the case of a 24-year-old woman suffering from a symptomatic portal vein thrombosis, confirmed by CT angiography, and acute CMV-related hepatitis. Besides a second generation oral contraceptive with estrogen and progesterone, not associated with smoking, the acute CMV infection was the only cause found to have provoked the venous thrombosis; a myeloproliferative disorder or biological thrombophilia were ruled out. The patient rapidly recovered with vitamin K antagonists (VKA) anticoagulant treatment. Eighteen cases of splanchnic vein thrombosis complicating acute CMV infection were found in the literature. All patients had acute hepatitis. The outcome was usually favorable with warfarin therapy for a period lasting 3 to 7 months. Antiviral treatment (anti-CMV) was used in three cases of severe infection. The antiviral therapy was given only in immunosuppressed patients. For immunocompetent patients, CMV infection is usually asymptomatic and clinical signs are often non-specific and mild, not requiring treatment.
This case report and the review of the literature recall the need to search for acute CMV infection in patients with portal thrombosis so a possible transient trigger for venous thromboembolism can be identified, avoiding extended anticoagulation.
门静脉血栓形成是一种罕见病症,其与急性巨细胞病毒(CMV)感染的关联虽为人所知,但鲜有报道。我们在此呈现一例24岁女性病例,该患者患有经CT血管造影确诊的有症状门静脉血栓形成及急性CMV相关性肝炎。除了一种含雌激素和孕激素且与吸烟无关的第二代口服避孕药外,急性CMV感染是唯一被发现引发静脉血栓形成的原因;排除了骨髓增殖性疾病或遗传性易栓症。患者接受维生素K拮抗剂(VKA)抗凝治疗后迅速康复。文献中发现18例急性CMV感染并发内脏静脉血栓形成的病例。所有患者均患有急性肝炎。使用华法林治疗3至7个月,通常预后良好。3例严重感染患者使用了抗病毒治疗(抗CMV)。抗病毒治疗仅用于免疫抑制患者。对于免疫功能正常的患者,CMV感染通常无症状,临床症状往往不具特异性且轻微,无需治疗。
本病例报告及文献回顾提示,对于门静脉血栓形成患者,有必要排查急性CMV感染,以便识别静脉血栓栓塞可能的短暂触发因素,避免长期抗凝。